FindTrial
Sign In

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2010-023948-33-ES
Enrollment
Unknown
Registered
2011-07-05
Start date
2011-08-16
Completion date
Unknown
Last updated
2012-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.0 Level: LLT Classification code 10036019 Term: Pollen allergy System Organ Class: 10021428 - Immune system disorders

Interventions

Product Name: Extracto alergénico de Dactylis glomerata Product Code: 181 Pharmaceutical Form: Cutaneous solution INN or Proposed INN: Extracto alergenico de Dactylis glomerata Concentration unit: mg/

Sponsors

LABORATORIOS LETI, S.L. UNIPERSONAL
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

MeasureTime frame
Timepoint(s) of evaluation of this end point: No aplica—

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Spain

Contacts

Public ContactArea de Investigación Clínica

Laboratorios Leti, S.L.U

mjgomez@leti.com34607285953

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026